MENU
Speakers

  • Dr. Trishe Leong, MMB(Hons) FRCPA MBA(Exec) MSHM AFRACMA PGDipMDPath
    Dr. Trishe Leong, MMB(Hons) FRCPA MBA(Exec) MSHM AFRACMA PGDipMDPath
    Medical Director of Pathology and Director of Anatomical Pathology, St. Vincent's Hospital Melbourne
    BIOGRAPHY
  • Dr. Rie Sakakibara, MD, PhD
    Dr. Rie Sakakibara, MD, PhD
    Assistant Professor, Department of Respiratory Medicine, Tokyo Medical and Dental University
    BIOGRAPHY
  • Dr. Tae-Jung Kim, MD, PhD
    Dr. Tae-Jung Kim, MD, PhD
    Director of Pathology, Yeouido St. Mary's Hospital
    BIOGRAPHY
  • Dr. Chelsee Hewitt, PhD
    Dr. Chelsee Hewitt, PhD
    Peter MacCallum Cancer Centre, Lead Scientist, Solid Somatic Molecular Pathology Laboratory
    BIOGRAPHY
  • Dr. Fernando López-Ríos, MD, PhD
    Dr. Fernando López-Ríos, MD, PhD
    Pathologist, Department of Pathology, Doce de Octubre University Hospital Madrid
    BIOGRAPHY
  • Dr. Jon Sherlock, PhD
    Dr. Jon Sherlock, PhD
    Director of Product Management, Oncology, Thermo Fisher Scientific
    BIOGRAPHY
  • Anna Sadio, BSc. MSc.
    Anna Sadio, BSc. MSc.
    Manager of Regulatory Affairs, EMEA, Thermo Fisher Scientific
    BIOGRAPHY
  • Dr. Marco Volante, MD, PhD
    Dr. Marco Volante, MD, PhD
    Professor of Pathology, Department of Oncology, University of Turin; Director Pathology Unit, San Luigi Hospital, Orbassano, Turin
    BIOGRAPHY
  • Dr. Robyn Marshall, MBChB, FCPATH (SA) HAEM, MMED HAEM (WITS), FRCPA (HAEM)
    Dr. Robyn Marshall, MBChB, FCPATH (SA) HAEM, MMED HAEM (WITS), FRCPA (HAEM)
    Oncolab Diagnostics, Pretoria, Haematologist, Director
    BIOGRAPHY
  • Matthew W. Beer
    Matthew W. Beer
    Director of North America Medical Affairs; Thermo Fisher Scientific
    BIOGRAPHY Rapid Genomic Profiling for Myeloid Malignancies - New Possibilities for Research Labs
  • Geoffrey Bien
    Geoffrey Bien
    Manager, Global Professional Services Genetic Sciences Group
    BIOGRAPHY
  • Rafael Ramirez, BS, MBA
    Rafael Ramirez, BS, MBA
    Global Business Development Manager; Thermo Fisher Scientific
    BIOGRAPHY Analytical Validation NGS - Inherited Disease Panels
  • Dr. Diana Morlote, M.D.
    Dr. Diana Morlote, M.D.
    Assistant Professor, Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham
    BIOGRAPHY
  • Dr. Daria Grafodatskaya, PhD, FCCMG
    Dr. Daria Grafodatskaya, PhD, FCCMG
    Assistant Professor Pathology and Molecular Medicine, McMaster University Hamilton; Head of Molecular Oncology, Hamilton Regional Laboratory Medicine Program
    BIOGRAPHY

OncomineWorld 2022: A Virtual NGS Education Meeting

Each year, the OncomineWorld virtual NGS education meeting brings together thousands of scientists and professionals who are dedicated to the advancement of genomic profiling in clinical oncology research.

Now in it's 4th iteration, OncomineWorld 2022 covers topics such as genomic profiling in solid tumors and hemato-oncology research, the IVDR transition, the latest advances in NGS workflows, and much more! In addition to general NGS education topics and updates, this year’s event also features content dedicated to labs who are new to or considering starting with NGS. Expand your knowledge of next-generation sequencing for clinical oncology research with this not-to-be missed event, now available on demand.

At OncomineWorld 2022, you will earn Continuing Education (CE) credits as you:

  • Recognize the many applications of next-generation sequencing in clinical oncology research
  • Discover how NGS can be easier, simpler and faster than you ever thought possible and acquire helpful tools to explore its possibilities
  • Describe new important biomarkers in clinical oncology research including HER2 and EGFR exon 20 insertions and identify the pros and cons of different testing techniques


What’s new at OncomineWorld 2022?

  • Watch a demonstration with live Q&A of the Ion Torrent Genexus System, the only true end-to-end NGS workflow, which allows you to advance from biological specimen to detailed report in as little as a single day with only two instruments
  • Visit the Oncomine Clinical Research Grant Hall to learn more about how Thermo Fisher Scientific supports molecular profiling in oncology research and see upcoming calls for grant applications
  • New to next-generation sequencing? Explore our virtual laboratories to see the many applications of NGS for precision oncology research, including emerging NSCLC biomarkers, comprehensive genomic profiling (CGP), liquid biopsy research, and hemato-oncology research.
  • Explore the virtual conference with the OncomineWorld Treasure Hunt! Earn points by visiting key rooms and uncovering hidden tokens
  • And so much more!


Speakers
  • Dr. Trishe Leong, MMB(Hons) FRCPA MBA(Exec) MSHM AFRACMA PGDipMDPath

    Medical Director of Pathology and Director of Anatomical Pathology, St. Vincent's Hospital Melbourne
    BIOGRAPHY
  • Dr. Rie Sakakibara, MD, PhD

    Assistant Professor, Department of Respiratory Medicine, Tokyo Medical and Dental University
    BIOGRAPHY
  • Dr. Tae-Jung Kim, MD, PhD

    Director of Pathology, Yeouido St. Mary's Hospital
    BIOGRAPHY
  • Dr. Chelsee Hewitt, PhD

    Peter MacCallum Cancer Centre, Lead Scientist, Solid Somatic Molecular Pathology Laboratory
    BIOGRAPHY
  • Dr. Fernando López-Ríos, MD, PhD

    Pathologist, Department of Pathology, Doce de Octubre University Hospital Madrid
    BIOGRAPHY
  • Dr. Jon Sherlock, PhD

    Director of Product Management, Oncology, Thermo Fisher Scientific
    BIOGRAPHY
  • Anna Sadio, BSc. MSc.

    Manager of Regulatory Affairs, EMEA, Thermo Fisher Scientific
    BIOGRAPHY
  • Dr. Marco Volante, MD, PhD

    Professor of Pathology, Department of Oncology, University of Turin; Director Pathology Unit, San Luigi Hospital, Orbassano, Turin
    BIOGRAPHY
  • Dr. Robyn Marshall, MBChB, FCPATH (SA) HAEM, MMED HAEM (WITS), FRCPA (HAEM)

    Oncolab Diagnostics, Pretoria, Haematologist, Director
    BIOGRAPHY
  • Matthew W. Beer

    Director of North America Medical Affairs; Thermo Fisher Scientific
    BIOGRAPHY
  • Geoffrey Bien

    Manager, Global Professional Services Genetic Sciences Group
    BIOGRAPHY
  • Rafael Ramirez, BS, MBA

    Global Business Development Manager; Thermo Fisher Scientific
    BIOGRAPHY
  • Dr. Diana Morlote, M.D.

    Assistant Professor, Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham
    BIOGRAPHY
  • Dr. Daria Grafodatskaya, PhD, FCCMG

    Assistant Professor Pathology and Molecular Medicine, McMaster University Hamilton; Head of Molecular Oncology, Hamilton Regional Laboratory Medicine Program
    BIOGRAPHY

Show Resources
You May Also Like
OCT 19, 2022 5:30 AM PDT
C.E. CREDITS
OCT 19, 2022 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
NOV 09, 2022 6:00 AM PST
NOV 09, 2022 6:00 AM PST
Labroots is pleased to host the annual 2022 Clinical Diagnostics and Research virtual event to be held on November 9th, 2022. Registration is open now....
NOV 09, 2023 6:00 AM PST
NOV 09, 2023 6:00 AM PST
Labroots is pleased to announce the 2023 Clinical Diagnostics and Research Virtual Event to be held on November 9th, 2023 packed with featured speakers....
SEP 06, 2022 6:00 AM PDT
SEP 06, 2022 6:00 AM PDT
Labroots to host the Microbiology Virtual Week on September 6, 2022. It offers discussions on the global development of treatment for Infectious Diseases....
SEP 05, 2023 6:00 AM PDT
SEP 05, 2023 6:00 AM PDT
Labroots to host the Microbiology Virtual Week on September 5-7, 2023. Offering discussions on the global development of treatment for Infectious Diseases....
MAY 16, 2023 6:00 AM PDT
MAY 16, 2023 6:00 AM PDT
Labroots is excited to announce our 11th Genetics Virtual Week held on May 16-18, 2023! Genetics Virtual Week will offer a multi-day content-rich program....
Agenda

On-demand presentations from 2022

In addition to 2022 presentations, watch dozens of talks from past OncomineWorld meetings

  • Lung pathology in the era of targeted therapies in patients with advanced NSCLC
    APR 07, 2022 12:00 PM +08
    Lung pathology in the era of targeted therapies in patients with advanced NSCLC
    Dr. Trishe Leong, MMB(Hons) FRCPA MBA(Exec) MSHM AFRACMA PGDipMDPath
    Medical Director of Pathology and Director of Anatomical Pathology, St. Vincent's Hospital Melbourne
    BIOGRAPHY
  • Exploratory factors relevant to success of the Ion Torrent™ Oncomine™ Dx Target Test
    APR 07, 2022 12:25 PM +08
    Exploratory factors relevant to success of the Ion Torrent™ Oncomine™ Dx Target Test
    Dr. Rie Sakakibara, MD, PhD
    Assistant Professor, Department of Respiratory Medicine, Tokyo Medical and Dental University
    BIOGRAPHY
  • Experience of ROS1 CDx platforms in the central laboratory of South Korea
    APR 07, 2022 12:45 PM +08
    Experience of ROS1 CDx platforms in the central laboratory of South Korea
    Dr. Tae-Jung Kim, MD, PhD
    Director of Pathology, Yeouido St. Mary's Hospital
    BIOGRAPHY
  • Peter MacCallum Cancer Centre validation of the Oncomine™ Precision Assay and experience with the Ion Torrent™ Genexus™ System
    APR 07, 2022 1:30 PM +08
    Peter MacCallum Cancer Centre validation of the Oncomine™ Precision Assay and experience with the Ion Torrent™ Genexus™ System
    Dr. Chelsee Hewitt, PhD
    Peter MacCallum Cancer Centre, Lead Scientist, Solid Somatic Molecular Pathology Laboratory
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Genexus System virtual demo with live Q&A
    APR 07, 2022 2:10 PM +08
    Genexus System virtual demo with live Q&A
    Andrew Hutchison
    Associate Director, Product Management
    BIOGRAPHY
  • RET aberrations and EGFR exon 20 insertions testing in the complex NSCLC biomarker landscape
    APR 07, 2022 3:00 PM CEST
    RET aberrations and EGFR exon 20 insertions testing in the complex NSCLC biomarker landscape
    Dr. Fernando López-Ríos, MD, PhD
    Pathologist, Department of Pathology, Doce de Octubre University Hospital Madrid
    BIOGRAPHY
  • APR 07, 2022 3:25 PM CEST
    An update on IVDR implementation plans and the Thermo Fisher Scientific NGS IVDR product pipeline
    Dr. Jon Sherlock, PhD, Anna Sadio, BSc. MSc.
    Continuing Education: P.A.C.E. CE | Florida CE
    Dr. Jon Sherlock, PhD
    Director of Product Management, Oncology, Thermo Fisher Scientific
    BIOGRAPHY
    Anna Sadio, BSc. MSc.
    Manager of Regulatory Affairs, EMEA, Thermo Fisher Scientific
    BIOGRAPHY
  • Implementation of next-generation sequencing in solid tumor testing using the Genexus platform
    APR 07, 2022 4:10 PM CEST
    Implementation of next-generation sequencing in solid tumor testing using the Genexus platform
    Dr. Marco Volante, MD, PhD
    Professor of Pathology, Department of Oncology, University of Turin; Director Pathology Unit, San Luigi Hospital, Orbassano, Turin
    BIOGRAPHY
  • Implementing the Ion Torrent™ Oncomine™ Leader-J assay for testing IGHV somatic hypermutation status in CLL samples
    APR 07, 2022 4:30 PM CEST
    Implementing the Ion Torrent™ Oncomine™ Leader-J assay for testing IGHV somatic hypermutation status in CLL samples
    Dr. Robyn Marshall, MBChB, FCPATH (SA) HAEM, MMED HAEM (WITS), FRCPA (HAEM)
    Oncolab Diagnostics, Pretoria, Haematologist, Director
    BIOGRAPHY
  • Genexus System virtual demo with live Q&A
    APR 07, 2022 5:00 PM CEST
    Genexus System virtual demo with live Q&A
    Andrew Hutchison
    Associate Director, Product Management
    BIOGRAPHY
  • HER2 mutation-an emerging biomarker in NSCLC
    APR 07, 2022 12:00 PM PDT
    HER2 mutation-an emerging biomarker in NSCLC
    Matthew Beer
    Director of North America Medical Affairs; Thermo Fisher Scientific
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • APR 07, 2022 12:35 PM PDT
    Analytical validation of a next-generation sequencing laboratory-developed test
    Rafael Ramirez, BS, MBA, Geoffrey Bien
    Rafael Ramirez, BS, MBA
    Global Business Development Manager; Thermo Fisher Scientific
    BIOGRAPHY
    Geoffrey Bien
    Manager, Global Professional Services Genetic Sciences Group
    BIOGRAPHY
  • Rapid next-generation sequencing for the study of acute myeloid leukemia
    APR 07, 2022 1:05 PM PDT
    Rapid next-generation sequencing for the study of acute myeloid leukemia
    Dr. Diana Morlote, M.D.
    Assistant Professor, Genomic Diagnostics and Bioinformatics, University of Alabama at Birmingham
    BIOGRAPHY
  • Ion Torrent™ Oncomine™ Precision Test on the Genexus System-first experience
    APR 07, 2022 1:25 PM PDT
    Ion Torrent™ Oncomine™ Precision Test on the Genexus System-first experience
    Dr. Daria Grafodatskaya, PhD, FCCMG
    Assistant Professor Pathology and Molecular Medicine, McMaster University Hamilton; Head of Molecular Oncology, Hamilton Regional Laboratory Medicine Program
    BIOGRAPHY
  • Genexus System virtual demo with live Q&A
    APR 07, 2022 2:00 PM PDT
    Genexus System virtual demo with live Q&A
    Andrew Hutchison
    Associate Director, Product Management
    BIOGRAPHY
  • APR 29, 2021 2:10 PM PDT
    Genexus System and Genexus Software Demo
    Andrew Hutchison, Uma Ramasubramanian
    Andrew Hutchison
    Associate Director, Product Management, Clinical Sequencing Division, Thermo Fisher Scientific
    Uma Ramasubramanian
    Product Manager, Clinical Sequencing Division, Thermo Fisher Scientific
  • Experience with the Oncomine Precision Assay on Genexus System
    APR 29, 2021 1:35 PM PDT
    Experience with the Oncomine Precision Assay on Genexus System
    Leomar Ballester, MD, PhD
    Assistant Professor, Molecular Genetic Pathology and Neuropathology, Co-Director, Molecular Diagnostics Laboratory, University of Texas Health​ Science Center at Houston
    BIOGRAPHY
  • Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
    APR 29, 2021 1:15 PM PDT
    Oncomine Reporter: A Powerful Tool for Oncology NGS Reports
    Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
    Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
    BIOGRAPHY
  • Current and upcoming pharma collaboration and IVD strategy
    APR 29, 2021 12:25 PM PDT
    Current and upcoming pharma collaboration and IVD strategy
    Garret Hampton
    President, Clinical Next Generation Sequencing, Thermo Fisher Scientific
    BIOGRAPHY
  • Point of care NGS in community practice
    APR 29, 2021 12:05 PM PDT
    Point of care NGS in community practice
    Brandon Sheffield, MD, FRCPC
    Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
    BIOGRAPHY
  • Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
    OCT 22, 2020 1:35 PM PDT
    Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
    Jane Bayani, PhD
    Principal Research Scientist, Ontario Institute for Cancer Research
    BIOGRAPHY
  • Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
    OCT 22, 2020 1:15 PM PDT
    Utilizing the Genexus System to Detect Complex Genetic Variants in Human Tissue Specimens
    Craig Mackinnon, MD, PhD
    Director, Genomic Diagnostics and Bioinformatics - Professor, Department of Pathology, University of Alabama at Birmingham
    BIOGRAPHY
  • Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
    OCT 22, 2020 12:25 PM PDT
    Clinical impact of Next-Generation Sequencing (NGS) Testing: A hematopathologist's perspective
    Megan S. Lim, MD, PhD
    Director of the Division of Hematopathology, Hospital of the University of Pennsylvania
    BIOGRAPHY
  • Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
    OCT 22, 2020 12:05 PM PDT
    Molecular Testing of NSCLC Biopsies: Making mountains out of molehills
    Carmen Kletecka, MD, FCAP, FASCP
    Medical Director, Molecular Oncology Diagnostics Laboratory - U.S. Department of Veterans Affairs
    BIOGRAPHY
  • First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
    OCT 22, 2020 4:40 PM CEST
    First Experiences with Oncomine™ Comprehensive Assay Plus for comprehensive genomic profiling
    Ines Raineri, MD
    Staff Pathologist, Institute for Pathology medica AG
    BIOGRAPHY
  • NGS evolution in Solid Tumours, from S5-XL to Genexus
    OCT 22, 2020 4:20 PM CEST
    NGS evolution in Solid Tumours, from S5-XL to Genexus
    Javier Hernandez-Losa, PhD
    Director of Molecular Biology Laboratory, Department of Pathology - Vall d´Hebron Hospital
    BIOGRAPHY
  • Next Generation rEvolution in Myeloid Neoplasms clinical research
    OCT 22, 2020 3:35 PM CEST
    Next Generation rEvolution in Myeloid Neoplasms clinical research
    Giada Rotunno, PhD
    Research Scientist, University of Florence
    BIOGRAPHY
  • NGS for precision oncology in solid tumors: from research to clinical practice
    OCT 22, 2020 3:05 PM CEST
    NGS for precision oncology in solid tumors: from research to clinical practice
    Nicola Normanno, MD
    Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    BIOGRAPHY
  • Latest Developments with the Genexus System
    OCT 22, 2020 1:35 PM SGT
    Latest Developments with the Genexus System
    Dr. Jose Luis Costa
    Medical Director, Thermo Fisher Scientific
    BIOGRAPHY
  • OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
    OCT 22, 2020 1:15 PM SGT
    OCA Plus DNA evaluation for comprehensive genomic profiling in clinical research
    Ahwon Lee, MD, PhD
    Professor, Catholic University of Korea and Pathologist, Seoul St. Mary's Hospital
    BIOGRAPHY
  • The role of PARPis and HRD testing in advanced ovarian cancer
    OCT 22, 2020 12:25 PM SGT
    The role of PARPis and HRD testing in advanced ovarian cancer
    Natalie Ngoi, MBBS, MMed, MRCP
    Associate Consultant, National University Cancer Institute, Singapore
    BIOGRAPHY
  • Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
    OCT 22, 2020 12:05 PM SGT
    Incorporating NGS in an Asian non-small cell lung cancer (NSCLC) population - a cost-effectiveness analysis
    Aaron Tan, PhD
    Oncology Fellow, Resident Physician, National Cancer Centre, Singapore
    BIOGRAPHY
  • Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
    MAY 14, 2020 7:05 PM EDT
    Haemato-Oncology Applications of BCR Immune Repertoire Sequencing
    Timothy Looney, PhD
    Director of Immunology and Bioinformatics, Singular Genomics
    BIOGRAPHY
  • Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
    MAY 14, 2020 6:40 PM EDT
    Genomic profiling of prostate cancer cells from urine using Oncomine Pan Cancer Cell Free Assay
    Jane Bayani, PhD
    Principal Research Scientist, Ontario Institute for Cancer Research
    BIOGRAPHY
  • First experience with the Ion Torrent Genexus Workflow
    MAY 14, 2020 5:40 PM EDT
    First experience with the Ion Torrent Genexus Workflow
    Kojo Elenitoba-Johnson, MD
    Director, Center for Personalized Diagnostics Director, Division of Precision and Computational Diagnostics, University of Pennsylvania Perelman School of Medicine
    BIOGRAPHY
  • MAY 14, 2020 5:00 PM EDT
    Molecular Profiling for Treatment Guidance of Hematologic Malignancies by Next Generation Sequencing
    Xia Li, Ph.D., DABMGG, CG(ASCP), FACMG
    Scientific Medicial Director of Genetics/Genomics Division at Sonora Quest Laboratories, Associate Professor of Pathology Department at University of Arizona
    BIOGRAPHY
  • Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
    MAY 14, 2020 4:40 PM CEST
    Lymphoid and Myeloid NGS Molecular Characterization - Assessing the Journey to Answers
    Marianne Grantham
    Clinical Scientist, Head of Cytogenetics and Molecular Haematology, Barts Health NHS Trust The Royal London Hospital
    BIOGRAPHY
  • Advantages and Challenges of Broad Molecular Profiling
    MAY 14, 2020 4:15 PM CEST
    Advantages and Challenges of Broad Molecular Profiling
    Ilaria Alborelli, PhD
    Scientific Operations Manager, Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital of Basel - Switzerland
    BIOGRAPHY
  • Genexus - A Major Step Forward in Diagnostic NGS
    MAY 14, 2020 3:30 PM CEST
    Genexus - A Major Step Forward in Diagnostic NGS
    Michael Hummel, PhD
    Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
    BIOGRAPHY
  • Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
    MAY 14, 2020 3:00 PM CEST
    Analysis of Solid Tumor Genomic Landscape in Liquid Biopsy
    Nicola Normanno, MD
    Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute Fondazione G. Pascale, Naples
    BIOGRAPHY
  • Emerging Biomarkers in Non-small Cell Lung Cancer
    MAY 14, 2020 3:00 PM CEST
    Emerging Biomarkers in Non-small Cell Lung Cancer
    Luca Quagliata, PhD
    Global Head of Medical Affairs, Clinical NGS and Oncology Division, Thermo Fisher Scientific
  • Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
    MAY 14, 2020 2:40 PM SGT
    Oncomine Precision Assay on Ion Torrent Genexus System for liquid biopsy sample
    Siew-Kee (Amanda) Low, PhD
    Group Leader for Cancer Neoantigen Vaccine Development Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (JFCR)
    BIOGRAPHY
  • First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
    MAY 14, 2020 2:15 PM SGT
    First Experience from New World of Easy NGS - Ion Torrent Genexus Workflow
    Philip Jermann, PhD
    Director of the Molecular Assay Development Unit, Institute of Pathology and Medical Genetics of Basel
    BIOGRAPHY
  • NATA Accreditation of Next Generation Sequencing for CDx Testing
    MAY 14, 2020 1:25 PM SGT
    NATA Accreditation of Next Generation Sequencing for CDx Testing
    Luke Hesson, PhD, FFScRCPA
    Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
    BIOGRAPHY
  • Test Validation in Medical Laboratories: the Australian Perspective
    MAY 14, 2020 1:25 PM SGT
    Test Validation in Medical Laboratories: the Australian Perspective
    Luke Hesson, PhD, FFScRCPA
    Laboratory Director, KCCG Sequencing Facility & Cancer Diagnostics​, Australia
    BIOGRAPHY
  • Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
    MAY 14, 2020 1:00 PM SGT
    Implementation of Multigene Testing for 1st line NSCLC - A Malaysian initiative
    Dr. Pathmanathan Rajadurai, MBBS, FRCPA, FRCPath
    Senior Consultant Pathologist and Laboratory Director
    BIOGRAPHY
C.E. Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Help

Demographics

Loading Comments...
Show Resources